ASSESSING WHETHER THERE IS A CANCER PREMIUM FOR THE VALUE OF A STATISTICAL LIFE

被引:33
|
作者
Viscusi, W. Kip [1 ]
Huber, Joel [2 ]
Bell, Jason [2 ]
机构
[1] Vanderbilt Univ, Nashville, TN 37203 USA
[2] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA
关键词
stated preference; risk; value of a statistical life (VSL); cancer; LATENCY; RISK; MORTALITY; DISEASE; WATER;
D O I
10.1002/hec.2919
中图分类号
F [经济];
学科分类号
02 ;
摘要
This article estimates whether there is a cancer risk premium for the value of a statistical life using stated preference valuations of cancer risks for a large, nationally representative US sample. The present value of an expected cancer case that occurs after a one decade latency period is $10.85m, consistent with a cancer premium that is 21% greater than the median value of a statistical life estimates for acute fatalities. This cancer premium is smaller than the premium proposed for policy analyses in the UK and the USA. There is also a greater premium for policies that reduce cancer risks to zero and for risk reductions affecting those who perceive themselves to have a greater than average probability of having cancer. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:384 / 396
页数:13
相关论文
共 50 条